Medpace Holdings (MEDP) Short term Debt (2015 - 2023)

Medpace Holdings (MEDP) posted Short term Debt of $55.0 million for Q2 2023, down 52.17% quarter-over-quarter from $115.0 million in Q1 2023, and down 77.97% year-on-year from $249.7 million in Q2 2022.

Medpace Holdings (MEDP) Short term Debt (2015 - 2023) Analysis & Trends

Medpace Holdings (MEDP) has reported Short term Debt for 6 consecutive years, with $55.0 million the latest figure, recorded in Q2 2023.

  • Short term Debt for Q2 2023 came in at $55.0 million, down 77.97% year-over-year; the trailing twelve-month figure through Jun 2023 was $55.0 million (down 77.97% YoY), and the FY2022 annual result was $50.0 million, changed N/A from the prior year.
  • Short term Debt was $55.0 million for Q2 2023 at Medpace Holdings, down from $115.0 million in the prior quarter.
  • Over five years, Short term Debt peaked at $249.7 million in Q2 2022 and troughed at $50.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Medpace Holdings 15.46 Bn 14.81 Bn 196.33 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 55.00 Mn
Mar 31, 2023 115.00 Mn
Dec 31, 2022 50.00 Mn
Sep 30, 2022 139.70 Mn
Jun 30, 2022 249.70 Mn
Jun 30, 2018 16.50 Mn
Mar 31, 2018 16.50 Mn
Dec 31, 2017 16.50 Mn
Sep 30, 2017 15.47 Mn
Jun 30, 2017 14.44 Mn
Mar 31, 2017 13.41 Mn
Dec 31, 2016 12.38 Mn
Dec 31, 2015 59,000.00